Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett’s Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study

<div>The function of studied polymorphisms based on previous studies; allele A of +61 A&gt;G epidermal growth factor (rs4444903) polymorphism leads to a reduction of <i>EGF</i> mRNA expression, and allele G of +142285 G&gt;A <i>EGF</i> receptor (<i>EGFR</i>, rs2227983) polymorphism increases the activity of EGFR [<a href="/journals/dm/2022/8790748/#B24">24</a>, <a href="/journals/dm/2022/8790748/#B25">25</a>].</div>

Disease Markers

fig1

Figure 1

Figure 1: Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett’s Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study 

Figure 1 | Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett’s Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study 